Current Drug Targets - CNS & Neurological Disorders
Title: Preface
Volume: 2 Issue: 4
Author(s): T. W. Rosahl and J. R. Atack
Affiliation:
Export Options
About this article
Cite this article as:
Rosahl W. T. and Atack R. J., Preface, Current Drug Targets - CNS & Neurological Disorders 2003; 2 (4) . https://dx.doi.org/10.2174/1568007X103020400ii
DOI https://dx.doi.org/10.2174/1568007X103020400ii |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
12
Related Articles
-
Syncope: Review of Monitoring Modalities
Current Cardiology Reviews The Impact of Ancillary Subunits on Small-Molecule Interactions with Voltage-Gated Potassium Channels
Current Pharmaceutical Design Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Growing up with Midazolam in the Neonatal and Pediatric Intensive Care
Current Drug Metabolism The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Neurotransmitter Regulation of Adult Neurogenesis: Putative Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds Are Antipsychotics Useful in the Treatment of Anorexia Nervosa? A Review of the Literature
Current Psychopharmacology Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry Repetitive Transcranial Magnetic Stimulation to Treat Substance Use Disorders and Compulsive Behavior
CNS & Neurological Disorders - Drug Targets Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats
CNS & Neurological Disorders - Drug Targets Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders
CNS & Neurological Disorders - Drug Targets Antiepileptic Drugs Based on the α-Substituted Amide Group Pharmacophore: From Chemical Crystallography to Molecular Pharmaceutics
Current Pharmaceutical Design Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Combined Virtual Screening Strategies
Current Computer-Aided Drug Design Familial Mediterranean Fever
Current Rheumatology Reviews Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry Congenital Disorders of Glycosylation (CDG): Update and Perspectives
Current Pediatric Reviews